Literature DB >> 15252837

Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells.

Preeti Kapoor1, Marnie M Saunders, Zhongyong Li, Zhiyi Zhou, Nate Sheaffer, Elaine L Kunze, Rajeev S Samant, Danny R Welch, Henry J Donahue.   

Abstract

The breast cancer metastasis-suppressor gene BRMS1 is downregulated in metastatic breast cancer cells. Previous reports have shown restoration of gap junctional intercellular communication (GJIC) in the metastatic human breast carcinoma cell line MDA-MB-435 (435) transfected with BRMS1 cDNA. Metastasis, to a large extent in most breast cancers, occurs to bone. However, the reason for this preferential metastasis is not known. We explored cell-to-cell communication between 435 carcinoma cells and a human osteoblastic cell line, hFOB1.19, to determine whether carcinoma cells can form gap junctions with bone cells and to explore the role of these heterotypic gap junctions and the BRMS1 gene in breast cancer metastasis to bone. 435 cells displayed greater cell-to-cell communication with hFOB 1.19 cells than with themselves. Transfection of BRMS1 into 435 cells increased homotypic gap junctional communication but did not significantly affect heterotypic communication with hFOBs. However, heterotypic communication of BRMS1 transfectants with hFOB cells was reduced relative to homotypic communication. In contrast, parental 435 cells displayed greater heterotypic communication with hFOBs relative to homotypic communication. Our results suggest that there are differences in the relative homotypic and heterotypic GJIC of metastasis-capable and -suppressed cell lines. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15252837     DOI: 10.1002/ijc.20318

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  Cancer interaction with the bone microenvironment: a workshop of the National Institutes of Health Tumor Microenvironment Study Section.

Authors:  Michael L Cher; Dwight A Towler; Shahin Rafii; David Rowley; Henry J Donahue; Evan Keller; Meenhard Herlyn; Eun Ah Cho; Leland W K Chung
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

2.  Alterations in Cx43 and OB-cadherin affect breast cancer cell metastatic potential.

Authors:  Zhongyong Li; Zhiyi Zhou; Henry J Donahue
Journal:  Clin Exp Metastasis       Date:  2008-01-10       Impact factor: 5.150

3.  Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis.

Authors:  Leah M Cook; Xuemei Cao; Alexander E Dowell; Michael T Debies; Mick D Edmonds; Benjamin H Beck; Robert A Kesterson; Renee A Desmond; Andra R Frost; Douglas R Hurst; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2012-01-13       Impact factor: 5.150

4.  BRMS1 coordinates with LSD1 and suppresses breast cancer cell metastasis.

Authors:  Rongfang Qiu; Hang Shi; Shuang Wang; Shuai Leng; Ruiqiong Liu; Yu Zheng; Wei Huang; Yi Zeng; Jie Gao; Kai Zhang; Yongqiang Hou; Dandan Feng; Yang Yang
Journal:  Am J Cancer Res       Date:  2018-10-01       Impact factor: 6.166

5.  Subsets of ATP-sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression.

Authors:  Thomas M Bodenstine; Kedar S Vaidya; Aimen Ismail; Benjamin H Beck; Anne R Diers; Mick D Edmonds; Gina T Kirsammer; Aimee Landar; Danny R Welch
Journal:  FEBS Lett       Date:  2011-11-24       Impact factor: 4.124

6.  Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer.

Authors:  L Kanczuga-Koda; S Sulkowski; A Lenczewski; M Koda; A Wincewicz; M Baltaziak; M Sulkowska
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

7.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.

Authors:  Alexandra C Silveira; Douglas R Hurst; Kedar S Vaidya; Donald E Ayer; Danny R Welch
Journal:  Cancer Lett       Date:  2008-12-13       Impact factor: 8.679

8.  A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.

Authors:  Natalya Frolova; Mick D Edmonds; Thomas M Bodenstine; Robert Seitz; Martin R Johnson; Rui Feng; Danny R Welch; Andra R Frost
Journal:  Tumour Biol       Date:  2009-07-16

9.  Detecting Pairwise Interactive Effects of Continuous Random Variables for Biomarker Identification with Small Sample Size.

Authors:  Amin Ahmadi Adl; Hye-Seung Lee; Xiaoning Qian
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2016-06-28       Impact factor: 3.710

Review 10.  A "class action" against the microenvironment: do cancer cells cooperate in metastasis?

Authors:  François-Clément Bidard; Jean-Yves Pierga; Anne Vincent-Salomon; Marie-France Poupon
Journal:  Cancer Metastasis Rev       Date:  2008-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.